Quality of life and voice following endoscopic resection or radiotherapy for early glottic cancer

Objectives: To assess whether proposed voice and quality of life (QoL) outcome measures were likely to be acceptable to patients previously treated for early glottic cancer by either radiotherapy or endoscopic resection, as well as looking for differences in QoL and voice between treatments. Design: Questionnaire‐based cohort study. Setting: Secondary care, three centres. Participants: All patients treated for T1a or in situ glottic carcinoma between 1997 and 2003. Fifty‐three patients were identified; those who had undergone salvage surgery or radiotherapy were excluded. A proportion refused to participate or could not be contacted and two patients had died of unrelated causes. Thirty‐six patients completed the trial with 18 from each treatment arm. Main outcome measures: Quality of voice as assessed by three questionnaires, Voice Handicap Index (VHI), Vocal Performance Questionnaire (VPQ), Voice Symptom Score (VoiSS) and perceptual analysis of voice by Grade, Roughness, Breathiness, Asthenia and Strained (GRBAS) assessment of vocal recordings. Quality of life as assessed by the Hospital Anxiety and Depression Scale (HADS), University of Washington Quality of Life Questionnaire (UW‐QoL), and the Functional Assessment of Cancer Therapy (FACT) questionnaire. Results: All patients included in the trial were able to complete the questionnaires; however, 19% required assistance of some kind. GRBAS assessment showed no difference between groups for any criteria. All QoL questionnaires gave equivalent good scores. All of the voice questionnaires showed no statistical difference between groups except for the emotional subscale of the VoiSS which showed a significantly better score for the radiotherapy arm (P = 0.04). Conclusion: All outcome measures were applicable and acceptable to the patient group. Overall QoL and voice appears similar despite treatment arm, apart from the emotional subscale of the VoiSS. A randomized controlled trial is required to further assess this question.     

聚焦超声治疗慢性宫颈炎500例临床分析

目的 探讨聚焦超声治疗宫颈炎的临床疗效.方法 收治慢性宫颈炎700例,分为聚焦超声治疗组(超生治疗组)500例,微波治疗对照组200例.观察其临床症状、体征及疗效.结果 超声治疗组中、重度宫颈炎的疗效明显高于微波对照组,差异有显著意义(P＜0.05);两种方法治疗后,宫颈修复过程中阴道排液、出血等并发症的发生率,超声治疗组明显低于微波对照组,差异有显著意义(P＜0.05).结论 聚焦超声治疗宫颈炎疗效确切,副作用及并发症少,是目前治疗宫颈炎的一种有效方法.     

Recommendations for the topical treatment of psoriasis

Several topical treatments are available for patients with psoriasis. Although individualization of the treatment remains important, there is a need for treatment recommendations to identify the best treatment out of the available treatments and to help with improvement in treatment compliance. In this communication we give our views on the assessment of severity of psoriasis. We provide recommendations for selection of treatments, reconciling the clearance phase and the long‐term management. Finally, we provide recommendations for the treatment of particular localizations: the scalp and psoriasis at sensitive sites.     

Women's Health Medicine 3:3 (May-June 2006) Self-appraisal Women and the ovary

Women and the ovary: self-appraisal     

中药醇提物对血液透析效果的影响

①目的　观察中药醇提物 (HD组方 )对血液透析效果的影响。②方法　选择我院终末期肾衰竭 (ES RD)病人 6 6例 ,已行维持性血液透析治疗 1年以上 ,随机分为常规组 32例 ,中药组 34例。常规组继续进行常规血液透析 ,中药组在常规透析的基础上 ,将透析液中加入HD组方 ,疗程均为 6个月。定期观察各组病人透析前、后血清尿素氮 (BUN)、肌酐 (Cr)、平均时间尿素氮浓度 (TACurea)、蛋白分解率 (PR)及G S指数 (KT/V值 )。③结果　中药组治疗后BUN、Cr水平与常规组同期比较明显降低 ,差别具有显著性 (t=2 .5 6 1、2 .4 98,P <0 .0 5 )。中药组治疗后TACurea较治疗前明显降低 ,差别具有极显著性 (t=2 .797,P <0 .0 1 ) ;而PR、KT/V值较治疗前明显升高 ,差别具有显著性 (t=2 .36 1、2 .4 98,P <0 .0 5 )。④结论　中药HD组方在透析液中的应用可提高ESRD病人透析效果及生活质量     

人参银杏合剂对模拟海拔8000米低氧大鼠的保护作用研究

目的 :研究人参银杏合剂对模拟海拔 80 0 0米低氧大鼠脑组织及血液内丙二酰二甲醛 (MDA)、乳酸含量的影响 ,并探讨其机理。方法 :用成年 SD大白鼠随机分为常氧对照组 (NC组 ) ,急性低氧组 (AH组 ) ,人参银杏合剂加低氧组 (GH组 ) ;分别测定各组的脑含水量、脑组织和血液 MDA和乳酸的含量。结果 :(1)与 NC组相比 ,AH组的脑含水量明显增高 (P<0 .0 1) ,GH组脑含水量较 AH组显著降低 (P<0 .0 5 )。(2 ) AH组脑组织匀浆和血液 MDA含量明显高于 NC组 (P<0 .0 1) ,GH组的 MDA含量较 AH组显著降低 (P<0 .0 1)。 (3) AH组脑组织匀浆和血液乳酸含量明显高于 NC组 (P<0 .0 1) ,GH组的乳酸含量较 AH组显著降低 (P<0 .0 1)。结论 :人参银杏合剂对高原缺氧脑损伤具有保护作用 ,其机理与其抗氧自由基、与膜脂质过氧化作用、改善细胞能量代谢有关。     

努力提高严重多发伤的基础研究和临床救治水平

目的:探讨提高严重多发伤的基础研究和临床救治水平。方法:结合我们的有关研究和参加抢救的临床救治体会,并引用国内外公开发表的相关论文及著作进行分析研究。结果:善于应用现有的先进科技手段,提高严重多发伤的基础研究和临床救治水平。降低伤残率和死亡率。结论:严重多发伤具有脏器损伤率高、出血性休克率高、感染率高、MODS发生率高、死亡率高等“五高”特点,所以其诊治的复杂性、紧迫性远远超过其他许多疾病。因此努力提高我国严重多发伤的基础研究及诊断和救治水平已是当务之急。     

依达拉奉防治缺血性脑损伤研究的新进展

近年来,依达拉奉脑保护作用的研究取得了很大进展,尤以对缺血性脑卒中和新生儿缺血缺氧性脑病的防治研究最为深入,而联合治疗策略也得到了广泛的重视.本文就近5年这些热点研究的新进展进行综述.